Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Miles Prince

Showing results (41-50 of 318) with videos related to

Pageof 32
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
Clinical studies of histone deacetylase inhibitorsH Miles Prince, Mark J Bishton, Simon J Harrison
Expert Opinion on Investigational Drugs|April 28, 2007
Histone deacetylase inhibitors in cancer therapyWalid K Rasheed, Ricky W Johnstone, H Miles Prince
Plastic and Reconstructive Surgery|March 30, 2012
Anaplastic large cell lymphoma and breast implants: five Australian casesKim O Taylor, Howard R Webster, H Miles Prince
The Australasian Journal of Dermatology|November 30, 2012
Exacerbation of lymphomatoid papulosis during rituximab therapyOlivia McCurdy, Chris McCormack, David Ritchie, et al.
Clinical Nuclear Medicine|October 5, 2019
A Novel Application of [18F]Fluorothymidine-PET ([18F]FLT-PET) in Clinical Practice to Quantify Regional Bone Marrow Function in a Patient With Treatment-Induced Cytopenias and to Guide "Marrow-Sparing" RadiotherapyBelinda A Campbell, Michael S Hofman, H Miles Prince
Platelets|June 2, 2015
Gastrointestinal bleeding in a chronic myeloid leukaemia patient precipitated by dasatinib-induced platelet dysfunction: Case reportLouise Kostos, Kate Burbury, Gaurav Srivastava, et al.
Blood|February 1, 2003
Pure red-cell aplasia due to parvovirus B19 infection in a patient treated with alemtuzumabKirsten E Herbert, H Miles Prince, David A Westerman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2007
Long-term survival and secondary acute leukemia after fotemustine therapy for metastatic melanomaSaar Gill, Jeremy Shapiro, David Westerman, et al.
Future Oncology (London, England)|June 13, 2009
Panobinostat (LBH589): a potent pan-deacetylase inhibitor with promising activity against hematologic and solid tumorsH Miles Prince, Mark J Bishton, Ricky W Johnstone
Eclinicalmedicine|November 11, 2024
Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort studyBelinda A Campbell, H Miles Prince, Julia J Scarisbrick
Pageof 32

Showing results (41-50 of 318) with videos related to

Sort By:
Pageof 32
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
Clinical studies of histone deacetylase inhibitorsH Miles Prince, Mark J Bishton, Simon J Harrison
Expert Opinion on Investigational Drugs|April 28, 2007
Histone deacetylase inhibitors in cancer therapyWalid K Rasheed, Ricky W Johnstone, H Miles Prince
Plastic and Reconstructive Surgery|March 30, 2012
Anaplastic large cell lymphoma and breast implants: five Australian casesKim O Taylor, Howard R Webster, H Miles Prince
The Australasian Journal of Dermatology|November 30, 2012
Exacerbation of lymphomatoid papulosis during rituximab therapyOlivia McCurdy, Chris McCormack, David Ritchie, et al.
Clinical Nuclear Medicine|October 5, 2019
A Novel Application of [18F]Fluorothymidine-PET ([18F]FLT-PET) in Clinical Practice to Quantify Regional Bone Marrow Function in a Patient With Treatment-Induced Cytopenias and to Guide "Marrow-Sparing" RadiotherapyBelinda A Campbell, Michael S Hofman, H Miles Prince
Platelets|June 2, 2015
Gastrointestinal bleeding in a chronic myeloid leukaemia patient precipitated by dasatinib-induced platelet dysfunction: Case reportLouise Kostos, Kate Burbury, Gaurav Srivastava, et al.
Blood|February 1, 2003
Pure red-cell aplasia due to parvovirus B19 infection in a patient treated with alemtuzumabKirsten E Herbert, H Miles Prince, David A Westerman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2007
Long-term survival and secondary acute leukemia after fotemustine therapy for metastatic melanomaSaar Gill, Jeremy Shapiro, David Westerman, et al.
Future Oncology (London, England)|June 13, 2009
Panobinostat (LBH589): a potent pan-deacetylase inhibitor with promising activity against hematologic and solid tumorsH Miles Prince, Mark J Bishton, Ricky W Johnstone
Eclinicalmedicine|November 11, 2024
Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort studyBelinda A Campbell, H Miles Prince, Julia J Scarisbrick
Pageof 32